Knight Therapeutics Inc. (TSX:GUD)
6.09
+0.09 (1.50%)
Mar 28, 2025, 4:00 PM EST
Knight Therapeutics Employees
Knight Therapeutics had 725 employees as of December 31, 2023. The number of employees increased by 27 or 3.87% compared to the previous year.
Employees
725
Change (1Y)
27
Growth (1Y)
3.87%
Revenue / Employee
498.39K CAD
Profits / Employee
5.81K CAD
Market Cap
607.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Green Thumb Industries | 4,800 |
dentalcorp Holdings | 9,900 |
Sienna Senior Living | 12,263 |
WELL Health Technologies | 1,507 |
Extendicare | 23,000 |
Curaleaf Holdings | 5,519 |
Trulieve Cannabis | 6,000 |
Cronos Group | 459 |
Knight Therapeutics News
- 2 days ago - Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico - Benzinga
- 8 days ago - Knight Therapeutics Inc. (KHTRF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Knight Therapeutics reports results - Seeking Alpha
- 8 days ago - Knight Therapeutics Reports Fourth Quarter and Year-End 2024 Results - GlobeNewsWire
- 15 days ago - Notice of Knight Therapeutics’ Fourth Quarter and Year End 2024 Results Conference Call - Financial Post
- 15 days ago - Notice of Knight Therapeutics' Fourth Quarter and Year End 2024 Results Conference Call - GlobeNewsWire
- 17 days ago - Knight Therapeutics to acquire Paladin Pharma for $120M - BNN Bloomberg
- 17 days ago - Knight Therapeutics to acquire Paladin for $120M - BNN Bloomberg